Latest news
17 de outubro de 2024
AbbVie wins FDA nod for infusion treatment for advanced Parkinson’s disease
by
in News
Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.
17 de outubro de 2024
Oil prices find a floor after 4-day slide despite disappointing Chinese stimulus
by
in News
Crude futures stabilized on Thursday, trading modestly higher after sliding for four sessions, but skepticism surrounding the latest stimulus measures announced by China overnight helped keep a lid on prices, analysts said.
Washington D.C. doesn’t work. You know what does? America itself.
by
in News
The U.S. as a whole is doing better than the media or our politicians let on.
17 de outubro de 2024
Elevance Health’s stock tumbles as profit dented by ‘unprecedented’ Medicaid challenges
by
in News
“We remain confident in the long-term earnings potential of our diverse businesses as we navigate a dynamic operating environment and unprecedented challenges in the Medicaid business,” Chief Executive Gail K. Boudreaux said in prepared remarks.
17 de outubro de 2024
NYSE stocks at new highs pump the market — but the VIX is sending mixed signals
by
in News
S&P 500 looks solid, and charts are positive for Amphenol, APA, wheat and Walgreens.
This presidential candidate is still the stock market’s bet to win the election
by
in News
The Dow’s indication of who will win the U.S. presidency deserves to be taken seriously.
A French crypto whale backing Trump may be moving markets many times that size
by
in News
There’s something funny going on in betting markets that seems to be leaking out into banking stocks, the dollar and Treasury yields.
